DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
NY-ESO-1-Specific TCR-Engineered T Cell Immunotherapy for Triple Negative Breast Cancer
Approved For Public Release